Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according to a real-world study presented at Retina 2025. Ferhina S. Ali, MD, MPH, ...
A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...
Boing Boing on MSN11h
Flies may hold the key to smart glasses that correct macular degenerationAmid the torrent of products announced earlier in January at the Consumer Electronics Show, like giant televisions and ...
Another common early symptom is blurry or distorted vision. Straight lines, like those on a doorframe or a tiled floor, may ...
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...
US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...
Outlook (OTLK) stock fell 10% after the company said it had completed a study analysis for its drug ONS-5010 and entered into ...
Retinal Biologics Industry. The retinal biologics market experienced significant growth in 2021, with total revenue reaching ...
“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...
University of California San Diego researchers have identified a U-shaped association between high-density lipoprotein (HDL) ...
Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback